Journal for ImmunoTherapy of Cancer (Sep 2021)
High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4+ and CD8+ neoantigen-specific T cells to promote antitumor immunity
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Sep 2021)